Point-of-Care Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-Care Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)
Market segment by Type, the product can be split into
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
Market segment by Application, split into
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Summary:
Get latest Market Research Reports on Point-of-Care Genetic Testing. Industry analysis & Market Report on Point-of-Care Genetic Testing is a syndicated market report, published as Global Point-of-Care Genetic Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Point-of-Care Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.